ResourceLife Sciences
Comparative economic analysis of magnetic bead-based and legacy processes for mAb manufacturing
29 Jan 2025Manufacturing monoclonal antibodies (mAbs) is a complex and costly process, but what if we could simplify it while saving money and boosting efficiency? Explore how magnetic bead-based processes can transform downstream mAb production. By consolidating cell removal and product capture into a single magnetic separation step, these novel approaches significantly reduce manufacturing costs, improve facility throughput, and enhance process efficiency. These findings highlight the potential of magnetic bead-based workflows to revolutionize mAb production with economic and sustainability benefits.
Links
Tags
AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.Monoclonal AntibodiesMonoclonal antibodies (mAbs) are lab-made molecules that can bind to specific antigens on cells, making them highly effective in treating cancers, autoimmune diseases, and infections. These targeted therapies are transforming the treatment landscape for many conditions. Browse our peer-reviewed product directory to find monoclonal antibodies for research and clinical applications; compare products, check reviews, and get pricing directly from manufacturers.Magnetic BeadsBioprocessingBioprocessing is the use of biological systems for the conversion of raw materials to desired products. This includes the research, development and manufacturing stages of production and can refer to food processing, small-molecule pharmaceutical manufacture, production of recombinant protein therapeutics, or the generation of renewable energy.